Pharma major Lupin Ltd reported a robust 74.1% year-on-year rise in its consolidated net profit, reaching Rs 852.63 crore for ...

The focus is on the company's improved profitability in the US markets and its plans to expand its business with new products ...

North America Q2 sales were Rs 1,971.1 crore, up 5.6 percent compared to Rs 1,866.6 crore, accounting for 36 percent of Lupin ...

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 98,802.92 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include ...

The Quarterly Results page of Lupin Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

Going ahead, Milan Vaishnav expects Lupin to resume its upmove from the current levels and go on to test Rs 2,300-2,350 levels.

However, what isn't spotlighted as much as those two points is the amount of third-party support the Switch has gotten since its launch in 2017. The Nintendo Switch has a lot of customization to it.

Treatment MarketThe global urinary tract infection (UTI) treatment market is poised for consistent growth, with an estimated ...

Ahead of the market opening on Thursday, Axis Direct picked five stocks that can generate profits in 5 to 15 days. These are ...

Our critics have scoured hundreds of shows to bring you the very best dramas and comedies to satisfy your cravings for ...

Hermione subplots, Pensieve flashbacks, and Quidditch showdowns are some of the scenes that didn’t make the cut in the movies ...